Skip to main content

Physiologie der Hodenfunktion

  • Chapter
Der alternde Mann
  • 30 Accesses

Zusammenfassung

Die Hoden sind beim Mann doppelseitig angelegte Organe und haben vor allem zwei Funktionen: Sie sind Hauptproduzent der männlichen Geschlechtshormone und Ort der Spermienproduktion. Sie sind damit in besonderer Weise für die Ausbildung und Aufrechterhaltung des männlichen Phänotypus verantwortlich. Dieser funktionelle Dualismus der Hoden begründet auch die Sonderstellung der Hoden innerhalb der endokrinen Organe.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Bagatell C, Bremner W: Testosterone in health and disease. Organon magazine on women & health (1999) 3:16–22

    Google Scholar 

  2. Jockenhövel F: Männlicher Hypogonadismus — Aktuelle Aspekte der Androgensubstitution. Uni-Med, Bremen (1999)

    Google Scholar 

  3. Kirby RS, Christmas TJ: Benigne Prostata-Hyperplasie. Mosby-Wolfe, London (1997)

    Google Scholar 

  4. Nieschlag E, Behre HM: Andrologie, Grundlagen und Klinik der reproduktiven Gesundheit des Mannes. Springer, Berlin (2000)

    Google Scholar 

  5. Nieschlag E, Behre HM: Testosterone — Action Deficiency Substitution. Springer, Berlin (1998)

    Book  Google Scholar 

  6. Oddens B, Vermeulen A: Androgens and the aging male. The parthenons publishing group, New York (1996)

    Google Scholar 

  7. Arver S, Dobs AS, Meikle AW: Long-term efficacy and safety of a permeation-enhanced testosterone trans dermal system in hypogonadal men. Clin Endocrinol (1997) 47:727–737

    Article  CAS  Google Scholar 

  8. Bagatell CJ, Bremner WJ: Androgen and prostagen effects on plasma lipids. Prog Cardiovasc Dis (1995) 38:255–271

    Article  PubMed  CAS  Google Scholar 

  9. Bartsch G, Rittmaster RS, Klocker H: Dihydrotestosteron and the concept of 5alphareductase inhibition in human benign prostatic hyperplasia. Eur Urol (2000) 37:367–380

    Article  PubMed  CAS  Google Scholar 

  10. Basaria S, Dobs AS: Risks versus benefits of testosterone therapy in elderly men. Drugs & Aging (1999) 15 (2):131–142

    Article  CAS  Google Scholar 

  11. Benagio G, Maggi S: Osteoporosis in men: an emerging problem. The Aging Male (2000) 3:59–64

    Article  Google Scholar 

  12. Figuerora RB: Mesterolone in Steatosis and Cirrhosis of the Liver. Acta Hepato-Gastroenterol (1973) 20:282–290

    Google Scholar 

  13. Foresta C, Zanatta GP, Busnardo B, Scanelli G, Scandellari C: Testosterone and calcitonin plasma levels in hypo gonadal osteoporotic young men, J Endocrinol Invest (1985) 8:377–379

    PubMed  CAS  Google Scholar 

  14. Gooren LJ: A Ten-Year Safety Study of the Oral Androgen Testosterone Undecanoate. J Androl (1994) 15:212–215

    PubMed  CAS  Google Scholar 

  15. Habenicht UF: Strogens for men: good or bad news. The Agin Male (1998) 1:73–79

    Article  Google Scholar 

  16. Marin P, Holmang S, Jonson L, Sjostrom L, Kvist H, Holm G, Lindstedt G, Bjontorp P: The effects of testosterone treatment on body composition and metabolism in middle-aged obes men. Int j Obes (1992) 16:991–997

    CAS  Google Scholar 

  17. Mayer D: Carcinogenic and anticarcinogenic effects of dehydroepiandrosterone in the liver of male and female rats. The Aging Male (1998) 1:56–66

    Article  Google Scholar 

  18. Moskilde L: Age-related changes in bone mass, structure, and strength — effects of loading. Z Rheumatol (2000) (Suppll) 59:1–9

    Article  Google Scholar 

  19. Nieschlag E, Behre HM: Andrologie, Grundlagen und Klinik der reproduktiven Gesundheit des Mannes. Springer, Berlin (2000)

    Google Scholar 

  20. Nieschlag E, Behre HM: Testosterone — Action deficiency substitution. Springer, Berlin (1998)

    Book  Google Scholar 

  21. Oddens B, Vermeulen A: Androgens and the aging male, The parthenon publishing group, New York (1996)

    Google Scholar 

  22. Resnick HE: Epidemiological aspects of diabetes in the aging male. The Aging Male (2000) 3:96–105

    Article  Google Scholar 

  23. Tenover JL: Testosterone and the Aging Male. J Androl (1997) 18:103–106

    PubMed  CAS  Google Scholar 

  24. Tremblay RR, Morales A: Canadian practice recommendations for screening, monitoring and treating men affected by andropause or partial androgen deficiency. The Aging Male (1998) 1:213–218

    Article  Google Scholar 

  25. Turner HE, Wass JAH: Gonadal function in men with chronic illness. Clin Endocrinol (1997) 47:379–403

    Article  CAS  Google Scholar 

  26. Vermeulen A, Kaufman JM: Androgens and cardiovascular disease in men and women. The Aging Male (1998) 1:35–50

    Article  Google Scholar 

  27. Vogel W, Klaiber EL, Broverman OM: A Comparison of the Antidepressant Effects of a Synthetic Androgen (Mesterolone) and Amitriptyline in Depressed Men. J Clin Psychiatry (1985) 46:6–8

    PubMed  CAS  Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2001 D. Fahlenkamp, K. J. G. Schmailzl, S. Lenk

About this chapter

Cite this chapter

Fahlenkamp, D. (2001). Physiologie der Hodenfunktion. In: Der alternde Mann. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56524-3_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-56524-3_2

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-62571-8

  • Online ISBN: 978-3-642-56524-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics